4 senior medical science liaison jobs found

Role: The Associate Account Director is the senior leader responsible for driving the growth, retention, and overall success of a portfolio of high-value client relationships. Acting as the strategic partner and escalation point for Account Managers, the AD ensures that client needs are met with proactive solutions, data-driven insights, and a structured approach to account management. The AD works closely with internal stakeholders—Sales, Product, Trading, and Leadership—to align business priorities, identify expansion opportunities, and optimize platform usage to drive long-term revenue.​ Job Overview: A healthcare-specific marketing platform working with some of the largest pharmaceutical brands and media agencies. We empower media planning, buying, and analytics teams with the tools they need to do their job, and do it well. By simplifying workflows that used to take days into seconds, integrating functionality that used to require multiple vendors into one, and...

Our team of expert medical affairs physicians and scientists at Regeneron bridge the gap between our innovative medicines and the scientific and healthcare community. As the Director Medical Affairs Hematology, you will represent Regeneron in Medical Affairs and Clinical Development providing scientific and medical leadership for our Hematology assets. In this strategic role, you will work within a multifunctional, matrix organization, aligning with Global and US teams to ensure that medical and clinical activities in Germany are in sync with global strategies and goals. You will collaborate with internal colleagues across Medical Affairs, Clinical Sciences, Operations, and Regulatory, and provide guidance to Commercial teams. As the key medical resource for Hematology in Germany, you will be instrumental in enhancing Regeneron's presence in the field, reporting to the Senior Medical Director DACH, and leading a dedicated medical team. A typical day might include: Acting as...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH.   Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c).   Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To...